Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative)

v3.20.2
Subsequent Events (Details Narrative) - Subsequent Event [Member]
$ / shares in Units, $ in Thousands
Nov. 13, 2020
USD ($)
Nov. 06, 2020
$ / shares
Oct. 24, 2020
$ / shares
Oct. 23, 2020
USD ($)
Oct. 22, 2020
USD ($)
ft²
Oct. 16, 2020
$ / shares
Oct. 01, 2020
$ / shares
shares
Common stock purchase to warrant | shares             50,000
Warrant exercise price | $ / shares             $ 5.00
Clinical laboratory improvement area | ft²         4,000    
Sale price of property $ 2,200            
Closing cost and other expenses $ 142            
Stock Purchase Agreement [Member]              
Aggregate purchase price for business         $ 2,500    
Consulting Agreement [Member]              
Aggregate purchase price for business       $ 300      
Consultant [Member]              
Debt instruement face amount         $ 300    
Unrelated Third party [Member] | Promissory note [Member]              
Debt instrument interest rate         10.00%    
Debt instrument maturity date         Dec. 31, 2020    
2010 Plan [Member]              
Exercise price | $ / shares   $ 9.49 $ 8.93     $ 7.04